Register entry

Chongqing Daxin Pharmaceutical Co., Ltd.

Registered sites
1
Drug products
12
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Chongqing Daxin Pharmaceutical Co., Ltd.ChongqingChinaActive ingredient (API) manufacture3000291692
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
-DaptomycinPOWDERBULK INGREDIENT
-DoramectinPOWDERBULK INGREDIENT
-LovastatinPOWDERBULK INGREDIENT
-MevastatinPOWDERBULK INGREDIENT
-Milbemycin OximePOWDERBULK INGREDIENT
-Mycophenolate OximePOWDERBULK INGREDIENT
-Mycophenolate sodiumPOWDERBULK INGREDIENT
-Mycophenolic AcidPOWDERBULK INGREDIENT
-SirolimusPOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TobramycinPOWDERBULK INGREDIENT
-Vancomycin HClPOWDERBULK INGREDIENT
-moxidectinPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.